IRIS Accounts Production v23.3.1.45 04968057 Board of Directors 30.11.21 29.11.22 29.11.22 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh049680572021-11-29049680572022-11-29049680572021-11-302022-11-29049680572020-11-30049680572020-12-012021-11-29049680572021-11-2904968057ns10:Originalns15:EnglandWales2021-11-302022-11-2904968057ns14:PoundSterlingns10:Original2021-11-302022-11-2904968057ns10:Originalns10:Director12021-11-302022-11-2904968057ns10:Original2021-11-302022-11-2904968057ns10:Original2022-11-2904968057ns10:Originalns10:PrivateLimitedCompanyLtd2021-11-302022-11-2904968057ns10:Originalns10:SmallEntities2021-11-302022-11-2904968057ns10:Originalns10:AuditExempt-NoAccountantsReport2021-11-302022-11-2904968057ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2021-11-302022-11-2904968057ns10:SmallCompaniesRegimeForAccountsns10:Original2021-11-302022-11-2904968057ns10:Originalns10:FullAccounts2021-11-302022-11-2904968057ns10:Originalns10:Director22021-11-302022-11-2904968057ns10:CompanySecretary1ns10:Original2021-11-302022-11-2904968057ns10:Originalns10:RegisteredOffice2021-11-302022-11-2904968057ns10:Original2021-11-2904968057ns10:Originalns5:CurrentFinancialInstruments2022-11-2904968057ns10:Originalns5:CurrentFinancialInstruments2021-11-2904968057ns5:ShareCapitalns10:Original2022-11-2904968057ns5:ShareCapitalns10:Original2021-11-2904968057ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-11-2904968057ns10:Originalns5:RetainedEarningsAccumulatedLosses2021-11-2904968057ns10:Originalns5:PlantMachinery2021-11-302022-11-2904968057ns10:Original2020-12-012021-11-2904968057ns10:Originalns5:PlantMachinery2021-11-2904968057ns10:Originalns5:PlantMachinery2022-11-2904968057ns10:Originalns5:PlantMachinery2021-11-2904968057ns10:Original2021-11-2904968057ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-11-2904968057ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2021-11-29
REGISTERED NUMBER: 04968057 (England and Wales)















PCR MANAGEMENT LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

29 NOVEMBER 2022






PCR MANAGEMENT LIMITED (REGISTERED NUMBER: 04968057)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 NOVEMBER 2022










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


PCR MANAGEMENT LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 29 NOVEMBER 2022







DIRECTORS: P C Robinson
M R Robinson





SECRETARY: P C Robinson





REGISTERED OFFICE: 53 Rectory Street
Epworth
Doncaster
DN91HX





REGISTERED NUMBER: 04968057 (England and Wales)






PCR MANAGEMENT LIMITED (REGISTERED NUMBER: 04968057)

BALANCE SHEET
29 NOVEMBER 2022

2022 2021
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 - 2,108
Investment property 5 240,976 240,976
240,976 243,084

CURRENT ASSETS
Debtors 6 27,094 30,667
Cash at bank 3,871 30,027
30,965 60,694
CREDITORS
Amounts falling due within one year 7 29,798 22,334
NET CURRENT ASSETS 1,167 38,360
TOTAL ASSETS LESS CURRENT
LIABILITIES

242,143

281,444

PROVISIONS FOR LIABILITIES - 270
NET ASSETS 242,143 281,174

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 242,043 281,074
242,143 281,174

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 29 November 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 29 November 2022 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

PCR MANAGEMENT LIMITED (REGISTERED NUMBER: 04968057)

BALANCE SHEET - continued
29 NOVEMBER 2022


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 November 2023 and were signed on its behalf by:





M R Robinson - Director


PCR MANAGEMENT LIMITED (REGISTERED NUMBER: 04968057)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 NOVEMBER 2022


1. STATUTORY INFORMATION

PCR Management Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 20% on reducing balance and 15% on reducing balance

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2021 - 2 ) .

PCR MANAGEMENT LIMITED (REGISTERED NUMBER: 04968057)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 29 NOVEMBER 2022


4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 30 November 2021
and 29 November 2022 26,902
DEPRECIATION
At 30 November 2021 24,794
Charge for year 2,108
At 29 November 2022 26,902
NET BOOK VALUE
At 29 November 2022 -
At 29 November 2021 2,108

5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 30 November 2021
and 29 November 2022 240,976
NET BOOK VALUE
At 29 November 2022 240,976
At 29 November 2021 240,976

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Other debtors 27,094 30,667

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Taxation and social security 10,479 18,014
Other creditors 19,319 4,320
29,798 22,334